IF YOU ARE LOOKING FOR AN EARLY-STAGE INVESTOR, CONTACT US NOW.

EARLY STAGE INVESTMENT

SynexCare

Our mission is to shape the future of healthcare using the latest and most advanced technologies. At SynexCare, we develop a new generation of medical products that suport activities in the field of modern diagnostics. Our products are dustinguished by the implementation of various artificial intelligence algorithms. Thanks to AI, it is possible to perform quick and accurate patient diagnostics, which improves the activities of medical personel. The SynexCare team is primarily people with a passion for creating vew medical solutions, with extensive experience, knowledge and commitment to shape a new era of healthcare.

CardioWaver is a mobile diagnostic recorder coupled with AI-enabled analytic software. The recorder has a 6D inertial sensor, which can assess patient movement, allowing for the reclassification of excitations and arrhythmias. The LTE module enables remote, fast transmission of examination files, and the signal reading is done through a patch electrode provided by SyneXcare, ensuring repeatable high-quality recordings. 

Link

EARLY STAGE INVESTMENT

Klub Aktywnych

The Active People Club is a platform dedicated to women 60+. In the Active People Club, we provide a carefully designed platform for online/live meetings and trainings. We support seniors in their lives in a simple and pleasant way, directly at home, through activities and community organized through web platform. We eliminate feeling of rejection, loneliness and suport physical health. 

Link

EARLY STAGE INVESTMENT

HI ORTHOTICS

HI Orthotics develops intelligent and innovative solutions that facilitate movement and other daily activities. Our mission is to create technologically advanced medical products that will support patients with lower limb dysfunctions and enable them to return to normal life without restrictions. Our goal is to ensure that movement is natural, free and safe, and that each patient can monitor their progress, thanks to the use of world-class technology.

Link

EARLY STAGE INVESTMENT

Virtual Monitor

Virtual Monitor is a comprehensive platform designed to streamline and simplify the process of conducting clinical trials. It incorporates a range of features and tools to help Sponsors, CROs, and Investigators conduct fully remote and paperless trials while simultaneously reducing costs and time spent on individual activities

Link

EARLY STAGE INVESTMENT

OPTI G

The Opti-G guidewire is a diagnostic device that allows precise diagnosis of the nature of the occlusion - neither angiography, which is an X-ray device that shows the course of the vessels after contrast is injected into the arterial lumen, nor cardiac CT or, even less, MRI give any feedback on the nature of the occlusion. Direct assessment is the way to simplify the procedure, shorten its duration and reduce the complications associated with the operators' learning curve. The Opti-G guidewire is primarily intended for use during interventional procedures for coronary artery disease


Link

EARLY STAGE INVESTMENT

ActivLife by Alreh Care

Alreh Medical is a company focused on providing innovative technologies for active rehabilitation to people with disabilities, tailored to their needs and financial possibilities. Their main product, the activLife Plug&Play, is a fully mechanical device that allows for a wide range of exercises for the upper limbs, abdominal and lower limbs, increasing mobility, balance training, and maintaining correct posture. With therapist panel control software and a camera that reads the positions of 25 human joints, activLife provides precise mapping of anatomical movements and monitoring of performance improvements. It also incorporates games, making rehabilitation a pleasurable experience The activeLife device allows for balance and cognitive training, which is an effective way to prevent falls in seniors. activLife is a highly effective tool in the prevention of falls and rehabilitation, enabling therapists to track their patients' progress with ease.

Link

EARLY STAGE INVESTMENT

DEMOX LAB

The project aims to develop an innovative diagnostic test for chronic inflammation of the eyelid margin caused by the Demodex Spp. mite. The current scientific studies indicate a 20% rate of infection with this mite among the world's human population, but there is a significant shortage of supplements on the market that allow ophthalmologists to apply appropriate treatment after diagnosing the presence of Demodex. The developed test will be non-invasive, fast, and affordable, and will be aimed at ophthalmologists, doctors of other specializations, and directly to patients. The resulting innovative product is expected to have key features such as ease of use, accuracy, affordability, integration with the knowledge base on common eye diseases, availability for any interested patient, and non-invasiveness. The successful implementation of the project will contribute to the global efforts to improve the diagnosis and treatment of common eye diseases caused by the Demodex pathogen.

Link

EARLY STAGE INVESTMENT

IDEAL BISTRO HEALTHCARE

Ideal Bistro is an integrated solution aimed at raising work standards and improving the quality of employment. The system provides catering services in the work zone, solving the problem of distributing ready-made meals, snacks, and beverages. Ideal Bistro system includes: a „Foodomat” device, which is an automated locker system for distributing hot or cold ready-made meals, a vending machine for distributing sweet and savory snacks, a water dispenser and vending machine for distributing canned and bottled drinks, a coffee machine and other hot beverage dispensers, such as tea and hot chocolate.

Link

EARLY STAGE INVESTMENT

MYCOGRESS by Mycocycle

Mycelium-fueled waste management, Mycoremediation and Mycocosmentics


Mycogress is creating a natural cosmetic raw material for the production of masks and cosmetic bases made from select strains of mycelium and apple waste.

Mycogress, alongside Mycocycle Inc, are pioneering natural waste solutions for a carbon neutral future.





Link

EARLY STAGE INVESTMENT

TARGA CELLS by TargaCell

In-vitro stem cell binding assay



Target Cells sp. z o.o. (PL) is collaborating with TargaCell Inc. (USA) to create a test that evaluates the capability of different fractions of human stem cells to adhere to the endothelium of heart tissues in vitro.


Link

EARLY STAGE INVESTMENT

CannabIBS by Greenspace Labs Inc.

Innovative OTC drug for the treatment of irritable bowel syndrome (IBS)


CannabIBS sp. z o.o. (PL) in cooperation with Greenspace Labs Inc. (USA) is conducting a pilot clinical trial to prove safety and effiacy of novel non-psychoactive cannabinoind-based treatment for Irritable Bowel Syndrome (IBS)









Link

EARLY STAGE INVESTMENT

The LINGHOS

We’re The Linghos, we will teach your kid how to speak correctly, so you don’t have to.

We make speech therapy engaging for the kids, convenient for their parents, and more technologically advanced for speech therapists.

Behind the project, there is a devoted team of international experts in such fields as Artificial Intelligence, game development, cinematic storytelling, voice recognition systems and speech therapy.





Link